Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;3(2):161-5.
doi: 10.1097/COH.0b013e3282f51b89.

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings

Elise Arrivé  1 , François Dabis
Affiliations

Prophylactic antiretroviral regimens for prevention of mother-to-child transmission of HIV in resource-limited settings

Elise Arrivé et al. Curr Opin HIV AIDS. 2008 Mar.

Abstract

Purpose of review: With the large international mobilization against HIV/AIDS, more HIV-infected people in resource-limited settings have access to antiretroviral therapy, including pregnant women. The relevance of simplified prophylactic antiretroviral regimens for the prevention of mother-to-child transmission of HIV may become questionable due to their lower efficacy and their higher risk of inducing viral resistance than fully suppressive antiretroviral therapy.

Recent findings: Field implementation of current recommendations, impact of prophylactic regimens on subsequent antiretroviral therapy response and possible new indications of antiretroviral therapy in pregnant women will be reviewed in this paper.

Summary: Prophylactic antiretroviral prevention of mother-to-child transmission regimens reached only 10% of the HIV-infected pregnant women in 2006, who were usually offered single-dose nevirapine only. The operational links between antenatal care and antiretroviral therapy programmes can now be documented and demonstrate good results in terms of safety and efficacy. The negative impact of single-dose nevirapine exposure on subsequent first-line antiretroviral therapy appears worse for mothers with advanced HIV disease at the time of delivery and short interval before antiretroviral therapy initiation. Strengthening the links between antenatal care and antiretroviral therapy programmes is critical for antiretroviral therapy-eligible HIV-infected pregnant women in terms of prevention of mother-to-child transmission and subsequent antiretroviral therapy response. The breastfeeding period could be a new indication for antiretroviral therapy in this population.

PubMed Disclaimer

References

    1. Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. 2006. [[Accessed September 20, 2007]]. Available at: http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. - PubMed
    1. Royal College of Obstetricians and Gynaecologists. Management of HIV in pregnancy. 2004. [[Accessed September 20, 2007]]. Available at: http://www.rcog.org.uk/resources/Public/pdf/RCOG_Guideline_39_low.pdf.
    1. Yeni P. Prise en charge médicale des personnes infectées par le VIH. 2006. [[Accessed September 20, 2007]]. Available at: http://www.sante.gouv.fr/htm/actu/yeni_sida/rapport_experts_2006.pdf.
    1. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006. [[Accessed September 20, 2007]]. Available at: http://www.who.int/hiv/pub/guidelines/pmtct/en/index.html.
    1. World Health Organization. Toward Universal Access. Scaling up priority HIV/AIDS interventions in the health sector. 2007. [[Accessed September 20, 2007]]. Available at: http://www.who.int/hiv/mediacentre/univeral_access_progress_report_en.pdf.